Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...
The American College of Chest Physicians (CHEST), the PF Warriors, the Rare Disease Diversity Coalition (RDDC)-a program at the Black ...
UVA Health researchers have discovered a potential way to predict which patients with severe COVID-19 are likely to recover well ...
University Hospitals Birmingham (UHB) has partnered with medical technology company, Qureight, to build more diverse artificial intelligence (AI) models that ...
In a recent study published in Cells, researchers evaluated idiopathic pulmonary fibrosis (IPF) pathophysiological differences by the intestinal microbiome and ...
In a recent study posted to the medRxiv* preprint server, researchers evaluated compositional and structural pulmonary alterations in PASC tissues. ...